Current treatments for diabetic retinopathy, including anti-vascular endothelial growth factor (VEGF) and laser photocoagulation, target the late proliferative stages of diabetic retinopathy and aim to reduce the vascular alterations seen at funduscopic examination [49]. This evidence concerns the gene VEGFA and diabetic retinopathy.